Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001641241-17-000001
Filing Date
2017-02-21
Accepted
2017-02-17 18:48:43
Documents
1
Effectiveness Date
2017-02-21
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6516
  Complete submission text file 0001641241-17-000001.txt   7570
Mailing Address 1201 BOYLSTON AVE. UNIT 417 SEATTLE WA 98101
Business Address 1201 BOYLSTON AVE. UNIT 417 SEATTLE WA 98101 6178182334
Cyrus Biotechnology, Inc. (Filer) CIK: 0001641241 (see all company filings)

EIN.: 471015686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-280988 | Film No.: 17622911